Skip to main content
Top
Published in: Journal of Inflammation 1/2008

Open Access 01-12-2008 | Research

IFN-gamma regulation of ICAM-1 receptors in bronchial epithelial cells: soluble ICAM–1 release inhibits human rhinovirus infection

Authors: Suzanne C Whiteman, Monica A Spiteri

Published in: Journal of Inflammation | Issue 1/2008

Login to get access

Abstract

Background

Intercellular adhesion molecule-1 (ICAM-1) is a critical target-docking molecule on epithelial cells for 90% of human rhinovirus (HRV) serotypes. Two forms of ICAM-1 exist, membranous (mICAM-1) and soluble (sICAM-1), both expressed by bronchial epithelial cells. Interferon-gamma (IFN-γ), a crucial Th-1 immuno-regulatory mediator, can modulate mICAM-1 expression; however its simultaneous effects on mICAM-1: sICAM-1 levels and their consequent outcome on cell infectivity have not been previously explored.

Methods

Primary normal human bronchial epithelial cells were pre-stimulated with IFN-γ (1 ng/ml for 24 h) and subsequently inoculated with HRV-14 or HRV-1b (TCID50 10 2.5). Epithelial surface ICAM-1 expression and soluble ICAM-1 release were measured at the protein and gene level by immunofluorescence and ELISA respectively; mRNA levels were semi-quantified using RT-PCR. Molecular mechanisms regulating ICAM-1 isoform expression and effects on epithelial cell infectivity were explored.

Results

In IFN-γ-biased cells infected with HRV-14, but not HRV-1b, mICAM-1 expression is down-regulated, with simultaneous induction of sICAM-1 release. This differential effect on HRV-14 receptor isoforms appears to be related to a combination of decreased IFN-γ-induced JAK-STAT signalling and proteolytic receptor cleavage of the membranous form in IFN-γ-biased HRV-14 infected cells. The observed changes in relative mICAM-1: sICAM-1 expression levels are associated with reduced HRV-14 viral titres.

Conclusion

These findings support the hypothesis that in epithelial cells conditioned to IFN-γ and subsequently exposed to HRV-14 infection, differential modulation in the ratio of ICAM-1 receptors prevails in favour of an anti-viral milieu, appearing to limit further target cell viral attachment and propagation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rothlein R, Mainolfi EA, Czajkowski M, Martin SD: A form of circulating ICAM-1 in human serum. J Immunol. 1991, 147: 3788-3793.PubMed Rothlein R, Mainolfi EA, Czajkowski M, Martin SD: A form of circulating ICAM-1 in human serum. J Immunol. 1991, 147: 3788-3793.PubMed
2.
go back to reference Whiteman SC, Bianco A, Knight RA, Spiteri MA: Human rhinovirus selectively modulates membranous and soluble forms of its intercellular adhesion molecule-1 (ICAM-1) receptor to promote epithelial cell infectivity. J Biol Chem. 2003, 278 (14): 11954-61. 10.1074/jbc.M205329200.PubMedCrossRef Whiteman SC, Bianco A, Knight RA, Spiteri MA: Human rhinovirus selectively modulates membranous and soluble forms of its intercellular adhesion molecule-1 (ICAM-1) receptor to promote epithelial cell infectivity. J Biol Chem. 2003, 278 (14): 11954-61. 10.1074/jbc.M205329200.PubMedCrossRef
3.
go back to reference Tosi MF, Stark JM, Wayne Smith C, Hamedani A, Gruenert DC, Infeld MD: Induction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines:effects on neutrophil-epithelial cell adhesion. Am J Respir Cell Mol Biol. 1992, 7: 114-221.CrossRef Tosi MF, Stark JM, Wayne Smith C, Hamedani A, Gruenert DC, Infeld MD: Induction of ICAM-1 expression on human airway epithelial cells by inflammatory cytokines:effects on neutrophil-epithelial cell adhesion. Am J Respir Cell Mol Biol. 1992, 7: 114-221.CrossRef
4.
go back to reference Bloeman PG, Tweel van den MC, Henricks PAJ, Engels F, Wagenaar SS, Rutten A, Nijkamp FP: Expression and modulation of adhesion molecules on human bronchial epithelial cells. Am J Respir Cell Mol Biol. 1993, 9: 586-593.CrossRef Bloeman PG, Tweel van den MC, Henricks PAJ, Engels F, Wagenaar SS, Rutten A, Nijkamp FP: Expression and modulation of adhesion molecules on human bronchial epithelial cells. Am J Respir Cell Mol Biol. 1993, 9: 586-593.CrossRef
5.
go back to reference Mickelson JK, Kukielka G, Bravenec JS, Mainolfi E, Rothlein R, Hawkins HK, Kelly JH, Wayne-Smith C: Differential expression and release of CD54 induced by cytokines. Hepatology. 1995, 22: 866-875.PubMed Mickelson JK, Kukielka G, Bravenec JS, Mainolfi E, Rothlein R, Hawkins HK, Kelly JH, Wayne-Smith C: Differential expression and release of CD54 induced by cytokines. Hepatology. 1995, 22: 866-875.PubMed
6.
go back to reference Look DC, Rapp SR, Keller BT, Holtzman M: Selective induction of intercellular adhesion molecule-1 by interferon-gamma in human airway epithelial cells. Am J Physiol. 1992, 263: L79-L87.PubMed Look DC, Rapp SR, Keller BT, Holtzman M: Selective induction of intercellular adhesion molecule-1 by interferon-gamma in human airway epithelial cells. Am J Physiol. 1992, 263: L79-L87.PubMed
7.
go back to reference Holden NS, Catley MC, Cambridge LM, Barnes PJ, Newton R: ICAM-1 expression is highly NF-kappaB-dependent in A549 cells. No role for ERK and p38 MAPK. Eur J Biochem. 2004, 271 (4): 785-791. 10.1111/j.1432-1033.2004.03982.x.PubMedCrossRef Holden NS, Catley MC, Cambridge LM, Barnes PJ, Newton R: ICAM-1 expression is highly NF-kappaB-dependent in A549 cells. No role for ERK and p38 MAPK. Eur J Biochem. 2004, 271 (4): 785-791. 10.1111/j.1432-1033.2004.03982.x.PubMedCrossRef
8.
go back to reference Sabatini F, Silvestri M, Sale R, Serpero L, Di Blasi P, Rossi GA: Cytokine release and adhesion molecule expression by stimulated human bronchial epithelial cells are downregulated by salmeterol. Respir Med. 2003, 97 (9): 1052-1060. 10.1016/S0954-6111(03)00137-9.PubMedCrossRef Sabatini F, Silvestri M, Sale R, Serpero L, Di Blasi P, Rossi GA: Cytokine release and adhesion molecule expression by stimulated human bronchial epithelial cells are downregulated by salmeterol. Respir Med. 2003, 97 (9): 1052-1060. 10.1016/S0954-6111(03)00137-9.PubMedCrossRef
9.
go back to reference Budnik A, Grewe M, Gyufko K, Krutman J: Analysis of the production of soluble ICAM-1 molecules by human cells. Exp Hemat. 1996, 24: 352-359.PubMed Budnik A, Grewe M, Gyufko K, Krutman J: Analysis of the production of soluble ICAM-1 molecules by human cells. Exp Hemat. 1996, 24: 352-359.PubMed
10.
go back to reference Rokhlin OW, Cohen MB: Soluble forms of CD44 and CD54 (ICAM-1) cellular adhesion molecules are released by human prostatic cancer cell lines. Cancer Letters. 1996, 107: 29-35. 10.1016/0304-3835(96)04339-X.PubMedCrossRef Rokhlin OW, Cohen MB: Soluble forms of CD44 and CD54 (ICAM-1) cellular adhesion molecules are released by human prostatic cancer cell lines. Cancer Letters. 1996, 107: 29-35. 10.1016/0304-3835(96)04339-X.PubMedCrossRef
11.
go back to reference Bianco A, Sethi SK, Allen JT, Knight RA, Spiteri MA: Th2 cytokines exert a dominant influence on epithelial cell expression of the major group human rhinovirus receptor, ICAM-1. Eur Respir J. 1998, 12: 619-626. 10.1183/09031936.98.12030619.PubMedCrossRef Bianco A, Sethi SK, Allen JT, Knight RA, Spiteri MA: Th2 cytokines exert a dominant influence on epithelial cell expression of the major group human rhinovirus receptor, ICAM-1. Eur Respir J. 1998, 12: 619-626. 10.1183/09031936.98.12030619.PubMedCrossRef
12.
go back to reference Subauste MC, Jacoby DB, Richards SM, Proud D: Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest. 1995, 96: 549-557. 10.1172/JCI118067.PubMedPubMedCentralCrossRef Subauste MC, Jacoby DB, Richards SM, Proud D: Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest. 1995, 96: 549-557. 10.1172/JCI118067.PubMedPubMedCentralCrossRef
13.
go back to reference Johnston SL, Papi A, Bates PJ, Mastronade JG, Monick MM, Hunninghake GW: Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J Immunol. 1998, 160: 6172-6181.PubMed Johnston SL, Papi A, Bates PJ, Mastronade JG, Monick MM, Hunninghake GW: Low grade rhinovirus infection induces a prolonged release of IL-8 in pulmonary epithelium. J Immunol. 1998, 160: 6172-6181.PubMed
14.
go back to reference Sethi SK, Bianco A, Allen JT, Knight RA, Spiteri MA: Interferon-gamma (IFN-gamma) down-regulates the rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) on human airway epithelial cells. Clin Exp Immunol. 1997, 110 (3): 362-369. 10.1046/j.1365-2249.1997.4221440.x.PubMedPubMedCentralCrossRef Sethi SK, Bianco A, Allen JT, Knight RA, Spiteri MA: Interferon-gamma (IFN-gamma) down-regulates the rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) on human airway epithelial cells. Clin Exp Immunol. 1997, 110 (3): 362-369. 10.1046/j.1365-2249.1997.4221440.x.PubMedPubMedCentralCrossRef
15.
go back to reference Arruda E, Crump CE, Marlin SD, Merluzzi VJ, Hayden FG: In vitro studies of the activity of soluble intercellular adhesion molecule-1. Antimicrobial agents and chemotherapy. 1992, 36 (6): 1186-1191.PubMedPubMedCentralCrossRef Arruda E, Crump CE, Marlin SD, Merluzzi VJ, Hayden FG: In vitro studies of the activity of soluble intercellular adhesion molecule-1. Antimicrobial agents and chemotherapy. 1992, 36 (6): 1186-1191.PubMedPubMedCentralCrossRef
16.
go back to reference Huguenel ED, Cohn Dockum DP, Greve JM, Fournel MA, Hammond Irwin R, Mahoney J, McClelland A, Muchmore E, Ohlin C, Scunderi P: Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1. Am J Respir Crit Care Med. 1997, 155: 1206-1210.PubMedCrossRef Huguenel ED, Cohn Dockum DP, Greve JM, Fournel MA, Hammond Irwin R, Mahoney J, McClelland A, Muchmore E, Ohlin C, Scunderi P: Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1. Am J Respir Crit Care Med. 1997, 155: 1206-1210.PubMedCrossRef
17.
go back to reference Turner RB, Wecker MT, Pohl G, Witek TJ, McNally E, St George R, Winther B, Hayden FG: Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA. 1999, 281 (19): 1797-1804. 10.1001/jama.281.19.1797.PubMedCrossRef Turner RB, Wecker MT, Pohl G, Witek TJ, McNally E, St George R, Winther B, Hayden FG: Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA. 1999, 281 (19): 1797-1804. 10.1001/jama.281.19.1797.PubMedCrossRef
18.
go back to reference Stratowa C, Audette M: Transcriptional regulation of the human intercellular adhesion molecule-1 gene: a short overview. Immunobiol. 1995, 193: 293-304.CrossRef Stratowa C, Audette M: Transcriptional regulation of the human intercellular adhesion molecule-1 gene: a short overview. Immunobiol. 1995, 193: 293-304.CrossRef
19.
go back to reference Wakatsuki T, Kimura K, Kimura F, Shinomiya N, Ohtsubo M, Ishizawa M, Yamamoto M: A distinct mRNA encoding a soluble form of ICAM-1 molecule expressed in human tissues. Cell adhesion Commun. 1995, 3: 283-292. 10.3109/15419069509081014.CrossRef Wakatsuki T, Kimura K, Kimura F, Shinomiya N, Ohtsubo M, Ishizawa M, Yamamoto M: A distinct mRNA encoding a soluble form of ICAM-1 molecule expressed in human tissues. Cell adhesion Commun. 1995, 3: 283-292. 10.3109/15419069509081014.CrossRef
20.
go back to reference Jackson AM, Alexandrov AB, Gribben SC, Esuvarnathan K, James K: Expression and shedding of ICAM-1 in bladder cancer and its immunotherapy. Int J Cancer. 1993, 55: 921-925. 10.1002/ijc.2910550608.PubMedCrossRef Jackson AM, Alexandrov AB, Gribben SC, Esuvarnathan K, James K: Expression and shedding of ICAM-1 in bladder cancer and its immunotherapy. Int J Cancer. 1993, 55: 921-925. 10.1002/ijc.2910550608.PubMedCrossRef
21.
go back to reference Hofer F, Gruenberger M, Kowalski H, Machat H, Huettinger M, Kuechler E, Blass D: Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc Natl Acad Sci USA. 91 (5): 1839-42. 10.1073/pnas.91.5.1839. 1994 Mar 1 Hofer F, Gruenberger M, Kowalski H, Machat H, Huettinger M, Kuechler E, Blass D: Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc Natl Acad Sci USA. 91 (5): 1839-42. 10.1073/pnas.91.5.1839. 1994 Mar 1
22.
go back to reference Joseph TD, Look DC: Specific inhibition of interferon signal transduction pathways by adenoviral infection. J Biol Chem. 2001, 276 (50): 47136-42. 10.1074/jbc.M102030200.PubMedCrossRef Joseph TD, Look DC: Specific inhibition of interferon signal transduction pathways by adenoviral infection. J Biol Chem. 2001, 276 (50): 47136-42. 10.1074/jbc.M102030200.PubMedCrossRef
23.
go back to reference Ramaswamy M, Shi L, Monick MM, Hunninghake GW, Look DC: Specific Inhibition of Type I Interferon Signal Transduction by Respiratory Syncytial Virus. Am J Respir Cell Mol Biol. 2004, 30 (6): 893-900. 10.1165/rcmb.2003-0410OC.PubMedCrossRef Ramaswamy M, Shi L, Monick MM, Hunninghake GW, Look DC: Specific Inhibition of Type I Interferon Signal Transduction by Respiratory Syncytial Virus. Am J Respir Cell Mol Biol. 2004, 30 (6): 893-900. 10.1165/rcmb.2003-0410OC.PubMedCrossRef
24.
go back to reference Najarro P, Traktman P, Lewis JA: Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation. J Virol. 2001, 75 (7): 3185-96. 10.1128/JVI.75.7.3185-3196.2001.PubMedPubMedCentralCrossRef Najarro P, Traktman P, Lewis JA: Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation. J Virol. 2001, 75 (7): 3185-96. 10.1128/JVI.75.7.3185-3196.2001.PubMedPubMedCentralCrossRef
25.
go back to reference Didcock L, Young DF, Goodbourn S, Randall RE: The V protein of simian virus 5 inhibits interferon signalling by targeting STAT-1 for proteasome-mediated degradation. J Virol. 1999, 73 (12): 9928-33.PubMedPubMedCentral Didcock L, Young DF, Goodbourn S, Randall RE: The V protein of simian virus 5 inhibits interferon signalling by targeting STAT-1 for proteasome-mediated degradation. J Virol. 1999, 73 (12): 9928-33.PubMedPubMedCentral
26.
go back to reference Nishio M, Tsurudome M, Ito M, Ito Y: Human parainfluenza virus type 4 is incapable of evading the interferon-induced antiviral effect. J Virol. 2005, 79 (23): 14756-68. 10.1128/JVI.79.23.14756-14768.2005.PubMedPubMedCentralCrossRef Nishio M, Tsurudome M, Ito M, Ito Y: Human parainfluenza virus type 4 is incapable of evading the interferon-induced antiviral effect. J Virol. 2005, 79 (23): 14756-68. 10.1128/JVI.79.23.14756-14768.2005.PubMedPubMedCentralCrossRef
27.
go back to reference Palosaari H, Parisien JP, Rodringuez JJ, Ulane CM, Horvath CM: STAT protein interference and suppression of cytokine signal transduction by measles V protein. J Virol. 2003, 77 (13): 7635-7644. 10.1128/JVI.77.13.7635-7644.2003.PubMedPubMedCentralCrossRef Palosaari H, Parisien JP, Rodringuez JJ, Ulane CM, Horvath CM: STAT protein interference and suppression of cytokine signal transduction by measles V protein. J Virol. 2003, 77 (13): 7635-7644. 10.1128/JVI.77.13.7635-7644.2003.PubMedPubMedCentralCrossRef
28.
go back to reference Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A: Inhibition of interferon signalling by dengue virus. PNAS. 2003, 100 (24): 14333-14338. 10.1073/pnas.2335168100.PubMedPubMedCentralCrossRef Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, Garcia-Sastre A: Inhibition of interferon signalling by dengue virus. PNAS. 2003, 100 (24): 14333-14338. 10.1073/pnas.2335168100.PubMedPubMedCentralCrossRef
29.
go back to reference Lin RJ, Liao CL, Lin E, Lin Y: Blocking of the alpha interferon-induced Jak-Stat signalling pathway by Japanese encephalitis virus infection. J Virol. 2004, 78 (17): 9285-9294. 10.1128/JVI.78.17.9285-9294.2004.PubMedPubMedCentralCrossRef Lin RJ, Liao CL, Lin E, Lin Y: Blocking of the alpha interferon-induced Jak-Stat signalling pathway by Japanese encephalitis virus infection. J Virol. 2004, 78 (17): 9285-9294. 10.1128/JVI.78.17.9285-9294.2004.PubMedPubMedCentralCrossRef
30.
go back to reference Lyons PD, Benveniste EN: Cleavage of membrane associated ICAM-1 from astrocytes: Involvement of a metalloprotease. Glia. 1996, 22: 103-112. 10.1002/(SICI)1098-1136(199802)22:2<103::AID-GLIA1>3.0.CO;2-8.CrossRef Lyons PD, Benveniste EN: Cleavage of membrane associated ICAM-1 from astrocytes: Involvement of a metalloprotease. Glia. 1996, 22: 103-112. 10.1002/(SICI)1098-1136(199802)22:2<103::AID-GLIA1>3.0.CO;2-8.CrossRef
31.
go back to reference Winther B, Arruda ETJ, Witek SD, Marlin MM, Tsianco DJ, Innes F, Hayde G: Expression of ICAM-1 in nasal epithelium and levels of soluble ICAM-1 in nasal lavage fluid during human experimental rhinovirus infection. Arch Otolaryngol Head Neck Surg. 2002, 128 (2): 131-6.PubMedCrossRef Winther B, Arruda ETJ, Witek SD, Marlin MM, Tsianco DJ, Innes F, Hayde G: Expression of ICAM-1 in nasal epithelium and levels of soluble ICAM-1 in nasal lavage fluid during human experimental rhinovirus infection. Arch Otolaryngol Head Neck Surg. 2002, 128 (2): 131-6.PubMedCrossRef
32.
go back to reference Hilderbrandt MH, Hopken KL, Rosseler ST, Bachert C: Increased levels of pro-inflammatory cytokines and soluble intercellular adhesion molecule-1 (sICAM-1) in nasal secretions in patients during naturally acquired rhinovirus infection. Allergologie. 1996, 1: 43- Hilderbrandt MH, Hopken KL, Rosseler ST, Bachert C: Increased levels of pro-inflammatory cytokines and soluble intercellular adhesion molecule-1 (sICAM-1) in nasal secretions in patients during naturally acquired rhinovirus infection. Allergologie. 1996, 1: 43-
Metadata
Title
IFN-gamma regulation of ICAM-1 receptors in bronchial epithelial cells: soluble ICAM–1 release inhibits human rhinovirus infection
Authors
Suzanne C Whiteman
Monica A Spiteri
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2008
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-5-8

Other articles of this Issue 1/2008

Journal of Inflammation 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.